4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-20-025969
Director sold 3,035 shares at $86.87 ($263,636)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bolzon Bradley J PhD Director | 2020-09-18 | Sale | −3,035 | $86.87 | $263,636 | 518,190 | I |
| Open-market sales · 3,035 sh · avg $86.87 · $263,636 | |||||||
Loading xslF345X03/doc4.xml…